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Abstract
TheWiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency charac-
terized by recurrent infections, thrombocytopenia, eczema, and high incidence of malig-
nancy and autoimmunity. The cellular mechanisms underlying autoimmune complications in
WAS have been extensively studied; however, they remain incompletely defined. We investi-
gated the characteristics of IL-10-producing CD19+CD1dhighCD5+ B cells (CD1dhighCD5+
Breg) obtained fromWas gene knockout (WKO) mice and found that their numbers were
significantly lower in these mice compared to wild type (WT) controls. Moreover, we found a
significant age-dependent reduction of the percentage of IL-10-expressing cells in WKO
CD1dhighCD5+ Breg cells as compared to age-matchedWT control mice. CD1dhighCD5+
Breg cells from older WKOmice did not suppress the in vitro production of inflammatory cyto-
kines from activated CD4+ T cells. Interestingly, CD1dhighCD5+ Breg cells from older WKO
mice displayed a basal activated phenotype which may prevent normal cellular responses,
among which is the expression of IL-10. These defects may contribute to the susceptibility to
autoimmunity with age in patients with WAS.
Introduction
TheWiskott-Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency that
causes recurrent infections, thrombocytopenia, eczema, and high incidence of malignancy
in affected patients. Autoimmune complications are also common in WAS and have been
described in 40% to 70% of patients in retrospective cohort studies [1, 2].
WAS is caused by mutations of theWAS gene that encodes for the WAS protein (WASp), a
multidomain-containing protein that regulates the actin cytoskeleton in hematopoietic cells
[3]. The role of WASp deficiency in the development of autoimmunity in WAS has been
explored extensively. Others and we have demonstrated that WASp-deficient natural
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regulatory T cells (nTreg) have defective suppression function of effector T cells and of B lym-
phocyte proliferation [4, 5, 6, 7, 8]. Recent observations in WASp-deficient (WKO) mice have
shown decreased numbers of interleukin (IL)-10-producing regulatory B cells (Breg), associ-
ated with increased Th1 and Th17 cells, as well as exacerbated pathology in an experimental
mouse arthritis model [9,10]. Altogether, these findings indicate the importance of WASp at
multiple levels of the regulatory cellular network of the immune system. We and others have
also shown that both humans affected with WAS and mouse models of the disease present
with intrinsic defects of B cell differentiation that are associated with increased production of
autoantibodies [11, 12, 13]. In addition, we have observed that WASp deficiency results in age-
dependent attrition of the immune system in humans [13, 14]. These clinical observations are
reflected in the WKOmouse model where we observed that animals older than 6 months of
age show significantly higher titers of antinuclear (ANA) and anti dsDNA antibodies and
increased severity of proliferative glomerulonephritis compared to age-matched wild type
(WT) controls [15, 16].
Based on these findings we set out to assess the presence, function, and effects of age on
splenic CD1dhighCD5+ B cells (CD1dhighCD5+ Breg), a subset of regulatory B cells that have
potent immune inhibitory capabilities through the secretion of IL-10 [17, 18, 19]. CD1dhighCD5+
Breg cells affect CD4+ T cell production of interferon- (IFN-) and tumor necrosis factor- (TNF-)
and are thought to thereby regulate the differentiation of CD4+ T cells into Th1/Th2/Th17 cells.
CD1dhighCD5+ Breg cells are also known to play a critical role in the pathogenesis of various
autoimmune mouse models, such as experimental autoimmune encephalomyelitis (EAE) and
murine systemic lupus erythematosus [18, 19].
However, while it has been reported that WKOmice have lower numbers of IL-10-produc-
ing, B220+ regulatory B cells [9, 10], detailed information about the specific CD1dhighCD5+
subset of Breg cell in WKOmice is lacking. In this study, we demonstrate that CD1dhighCD5+
Breg cells are reduced in numbers in WKOmice and become functionally impaired in older
animals, which provides additional insights into the mechanisms leading to immune dysregu-
lation in WAS.
Materials and Methods
Mice
Was -/y,Was -/- (129S6/SvEvTac-Wastm1Sbs/J) (WKO), and 129S6/SvEvTac (WT) mice were
used in experiments approved by the National Human Genome Research Institute Animal
Care and Use Committee. All mice were bred in a specific pathogen-free barrier facility and
used from 6 weeks to under 1.5 years of age.
Cell preparations
Single-cell suspensions from spleens were generated by gentle dissection and treatment in
ACK lysis buffer (Lonza, Walkersville, MD, USA) followed by passage through 70 μm cell
strainers (BD Biosciences, San Jose, CA, USA) and suspension in complete medium (RPMI
1640 media containing 10% FCS, 200 μg/ml penicillin, 200 U/ml streptomycin, 4 mM L-gluta-
mine and 5×10−5 M 2-mercaptoethanol (all from Gibco, Gaithersburg, MD, USA).
A MACS cell separator (Milteny Biotech, Auburn, CA, USA) was used to purify lymphocyte
populations according to the manufacturer’s instructions. CD4+ T cells were positively selected
from splenocytes using anti-mouse CD4-coated microbeads (Milteny Biotech). The cells were
enriched a second time using a fresh MACS column to obtain>95% cell purities.
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To purify CD19+CD1dhighCD5+ Breg cells, CD4-depleted cells were further subjected to cell
sorting using a BD FACSAria III sorter (BD Biosciences) based on their expression of CD19,
CD1d, and CD5 with obtained purities of>95%.
Flow cytometry analysis of cell surface markers and intracellular IL-10
synthesis
FITC-, PE-, APC-, PerCP-, or APC-Cy7-conjugated anti-CD19 (1D3), CD5 (53–7.3), CD1d
(1B1), CD4 (RM4-5), CD45R/B220 (RA3-6B2), CD69 (H1.2F3), IL-10 monoclonal antibodies
and isotype controls were obtained from BD Biosciences and Biolegend, San Diego, CA, USA.
Staining of cell surface markers was performed using standard procedures. The gating strategy
used to assess the frequency of CD1dhighCD5+ Breg cells in mouse spleens are described in
Figure in S1 Fig. For intracellular staining of IL-10 production, isolated splenocytes were resus-
pended (2×106 cells/ml) in medium containing LPI (10 μg/ml lipopolysaccharides (LPS; Sigma
Aldrich, St. Louis, MO, USA), 50 ng/ml phorbol 12-myristate 13-acetate (PMA; Sigma
Aldrich), 500 ng/ml ionomycin (Sigma Aldrich)), and 2 μl of GolgiStop (BD Biosciences) and
incubated with 5% CO2 at 37°C for 5 hrs (LPI stimulation). Fc receptors were then blocked
with purified rat anti-mouse Fc-receptor-specific mAb (CD16/CD32 (2.4G2) antibody; BD
Biosciences) before cell-surface staining and then fixed and permeabilized with the Cytofix/
Cytoperm kit (BD Biosciences) according to the manufacturer’s instructions. Background
staining was assessed using non-reactive, isotype-matched control mAbs. We defined IL-
10-positive cells by gating to exclude>99.9% of non-reactive cells. All data were collected on
FACS Calibur and LSRII instruments (BD Biosciences) and analyzed with FlowJo software
(TreeStar, Ashland, OR, USA).
ELISA
Purified CD1dhighCD5+ Breg cells (1×105 cells/ml) were cultured in 1 ml of complete medium
with or without LPI for 5 hrs. IL-10 concentration in culture supernatant was then quantified
using the IL-10 OptEIA ELISA kit (BD Pharmingen, San Diego, CA, USA) following the manu-
facturer’s protocol. All assays were conducted in triplicate.
Cell co-culturing assay
Isolated WT CD4+ T cells and WT/WKO CD1dhighCD5+ Breg cells were cultured in complete
medium in 96-well flat-bottom plates in the presence of plate-bound anti-CD3 (0.1 μg) and sol-
uble anti-CD28 (1 μg/ml) antibodies (eBioscience, San Diego, CA, USA). For co-culture experi-
ments, WT CD4+ T cells (1×105 cells in 100μl/well) and either WT or WKO CD1dhighCD5+
Breg cells were cultured at a ratio of 1:1 for 72 hrs.
After stimulation, concentration of cytokines in culture supernatants was measured using
the IFN- ELISA MAXTM kit (Biolegend), and the mouse-TNF- kit (OptEIA ELISA; BD Phar-
mingen) following the manufacturer’s protocols.
Cultured cells were stained with anti-CD45R/B220, CD19 and CD69. CD4+ T cells were
analyzed as CD19-negative, B220-negative cells. Dead cells were excluded using propidium
iodide staining. All experiments were repeated at least three times. For all experiments, age-
matched WT control mice were used. Pooling of splenocytes from multiple mice was used, if
necessary, for examination of minor cell subsets.
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Statistical analysis
Data are shown as mean and standard deviation (SD). Significant differences (p<0.05) between
sample means were determined using Student’s t-test. Percentage values were statistically ana-
lyzed after angular transformation and using the Mann-Whitney test.
Results and Discussion
The number of splenocytes obtained fromWKOmice (8.5±3.68×107 cells/mouse; N = 45) was
not significantly different from that of WT animals (9.4±3.64×107 cells/mouse; N = 76). How-
ever, and as expected (3, 9, 10), the number of total splenic CD19+ B cells observed in WKO
mice (2.6±1.23×107 cells/mouse; N = 44) was significantly lower than in WTmice (3.7
±1.83×107 cells/mouse; N = 75) (p<0.05).
The percentage of CD1dhighCD5+ Breg cells within WKO splenic CD19+ B cells was statisti-
cally lower than in WT splenic B cells (1.3±0.75% vs 3.8±2.89%, p<0.05) (Fig 1a). Conse-
quently, the absolute number of CD1dhighCD5+ Breg cells in WKOmice (0.3±0.22×106 cells/
mouse) was approximately 5 times lower than in WT animals (1.5±1.75×106 cells/mouse,
p<0.05). Age did not appear to be a factor in this observation, as both younger (<6 months
of age) and older (>6 months of age) WKOmice presented significantly lower number of
CD1dhighCD5+ Breg cells compared to WT controls (Fig 1b, p<0.05).
We then assessed the proportion of IL-10-producing CD1dhighCD5+ Breg cells within WT
andWKO splenocytes in resting conditions (Before) and 5hrs after stimulation with LPI (After,
Fig 2a). For both resting and stimulated splenocytes from younger animals, the proportion of
IL-10-producing CD1dhighCD5+ Breg cells did not differ betweenWT andWKOmice (Fig 2b).
However, in WKOmice older than 6 months, the percentage of IL-10+ CD1dhighCD5+ Breg
cells both in resting and stimulated splenocytes was statistically lower than that detected in age-
matchedWT control mice. Moreover, the percentage of IL-10+ CD1dhighCD5+ Breg cells in
older WKOmice cells was also statistically lower compared to younger WKOmice (p<0.05)
(Fig 2b).
Accordingly, while the concentration of IL-10 detected in the culture medium of stimulated
CD1dhighCD5+ Breg cells from younger WKOmice did not differ fromWT control mice, IL-
10 production by CD1dhighCD5+ Breg cells from older WKOmice was statistically lower than
that observed in age-matched WT CD1dhighCD5+ Breg cells (Fig 2c, p<0.002).
CD1dhighCD5+ Breg cells have been reported to suppress the activation of CD4+ T cells and
affect their production of IFN- and TNF- (19). Based on the observations described above, we
hypothesized that CD1dhighCD5+ Breg cells from older WKOmice would show defective IL-
10-mediated suppressing capabilities compared to CD1dhighCD5+ Breg cells from older WT
animals, as well as younger WKOmice. Indeed, in our co-culture experiments of CD4+ T cells
and CD1dhighCD5+ Breg cells, WKO CD1dhighCD5+ Breg cells from older WKOmice showed
lower suppression of CD69 expression on WT CD4+ T cells compared to CD1dhighCD5+ Breg
cells from age-matched WT (Fig 3a and 3b, p<0.05). We also noted that the CD69 expression
levels on cultured CD1dhighCD5+ Breg cells from older WKOmice was statistically lower than
that of CD1dhighCD5+ Breg cells from age-matched WT controls (p<0.05). Of note, no differ-
ences were observed between the effects of CD1dhighCD5+ Breg cells from younger WKO
andWT mice on the expression of CD69 on the surface of co-cultured CD4+ T cells (Fig 3a
and 3b).
We also found that the concentration of IFN- and TNF- in the medium of co-cultures of
WT CD4+ T and WKO CD1dhighCD5+ Breg cells from older mice was statistically higher than
that from co-cultures of control WT CD4+ T andWT CD1dhighCD5+ Breg cells (IFN-: p<0.05,
TNF-: p<0.02) (Fig 3c).
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To investigate whether the lower production of IL-10 by CD1dhighCD5+ Breg cells from
older WKOmice was due to reduced effects of LPI stimulation, we assessed the expression
levels of CD69 on the surface of CD1dhighCD5+ Breg cells before and after LPI stimulation
(Fig 4a).
Interestingly, we found that the CD69 expression levels on CD1dhighCD5+ Breg cells from
older WKOmice before LPI stimulation was statistically higher than that of CD1dhighCD5+
Breg cells from age-matched WT controls and younger WKOmice (Fig 4b, p<0.001). In con-
trast, after LPI stimulation, the CD69 expression levels of CD1dhighCD5+ Breg cells from older
WKOmice were statistically lower than that of CD1dhighCD5+ Breg cells from age-matched
WT and younger WKO controls (Fig 4c, p<0.05 and 0.001, respectively).
Our observations show that age plays a significant role in shaping the CD19+CD1dhighCD5+
B cell compartment of WKOmice. When analyzed at>6 months of age, WKOmice present
significantly lower percentages of IL-10 producing CD1dhighCD5+ Breg cells compared to both
WT control and young WKOmice. This condition results in reduced suppression of CD4+ T-
cell activation and decreased inhibition of IFN- and TNF- production. Altogether, older WKO
mice show significantly impaired regulatory B cell function that may contribute to the onset
of the known autoimmune complications observed in this animal model and possibly to the
age-dependent exacerbation of the autoimmune phenotype that we have previously described
[15, 20].
Further studies are needed to uncover the mechanisms leading to these findings. As shown
by Bouma et al. [9], WKO mice of less than 6 months of age show a more severe experimental
arthritis compared to control mice that can be ameliorated by adoptive transfer of Breg cells.
By comparing equal numbers of WT and WKO CD1dhighCD5+ Breg cells, we demonstrate
here that WKO CD1dhighCD5+ Breg cells from young WKOmice maintain the ability of
secreting normal amounts of IL-10. The increased severity of the autoimmune arthritis
Fig 1. Characteristics of CD1dhighCD5+ Breg cells in WKOmice. a: Representative results of the percentages of CD1dhighCD5+ Breg cells detected within
total splenic CD19+ B cells of WT andWKOmice. b: Total number of splenic CD1dhighCD5+ Breg cells in younger (<6 months old) and older (>6 months old)
mice. Average numbers (±SD) of CD1dhighCD5+ Breg cells from 23–49 mice are shown. *p<0.002 (Student’s t-test).
doi:10.1371/journal.pone.0139729.g001
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observed in these mice, therefore, can simply be due to the reduction of Breg cell frequency
observed by Bouma et al. and the lower absolute numbers of CD1dhighCD5+ Breg cells identi-
fied by us in WKOmice. Interestingly, we demonstrated that IL-10 secretion of WKO
CD1dhighCD5+ Breg cells from older mice becomes significantly defective. Similar to the obser-
vations we previously made in WKO nTreg cells that have significantly reduced ability of
Fig 2. IL-10 production byWKOCD1dhighCD5+ Breg. a: Representative flow-cytometry histograms showing IL-10-producing cells identified within
CD1dhighCD5+ Breg cells of younger (<6 months old) and older (>6 months old) mice before and 5 hrs after stimulation with LPS, PMA, and ionomycin. b:
Percentage of IL-10-positive cells within CD1dhighCD5+ Breg. White bars indicate the percentage (±SD) of IL-10-positive cells before stimulation (Before).
Black bars indicate the percentage (±SD) IL-10 positive cells 5 hrs after stimulation with LPS, PMA and ionomycin (After). Each histogram represents data
observed in 10 to 27 mice. c: IL-10 production after stimulation of CD1dhighCD5+ Breg cells with LPS, PMA and ionomycin. Bar graphs indicate mean (±SD)
of 3–5 experiments in which CD1dhighCD5+ Breg cells were pooled from 6–10 mice were analyzed. *p<0.05, **p<0.002 (Student’s t-test).
doi:10.1371/journal.pone.0139729.g002
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granzyme B degranulation [8], the defective secretion of IL-10 byWKO CD1dhighCD5+ Breg
cells may be attributable to defective cytokine trafficking and release due to aberrant cytoskeletal
reorganization in the absence of WASp expression. However, the absence of similar findings in
CD1dhighCD5+ Breg cells from younger WKOmice makes this explanation somewhat less com-
pelling. On the other hand, our findings that WKO CD1dhighCD5+ Breg cells from older mice
present with significantly higher levels of CD69 expression in basal conditions suggest that the
functional impairment of CD1dhighCD5+ Breg cells from older WKOmice may be at least in
part due to abnormal activation, possibly translating in defective responses to further stimula-
tion. The reasons underlying the increased levels of cellular activation in CD1dhighCD5+ Breg
cells from older WKOmice are at present unclear.
Fig 3. CD1dhighCD5+ Breg suppression activity. a: Representative results showing the fluorescent intensity of CD69 expression onWT CD4+ T cells and
CD1dhighCD5+ Breg cells 72 hrs after co-culture with anti-CD3/CD28. b: Fluorescence intensity of CD69 expression on the surface of CD4+ T cells and
CD1dhighCD5+ Breg cells. Fluorescence intensity was expressed as delta mean fluorescence intensity (ΔMFI), which was calculated by subtracting the
intensity of expression in unstimulated cells from that of cultured cell populations. Bar graphs indicate mean ± SD. *p<0.05 (Student t-test). c: Concentrations
of cytokine (IFN- and TNF-) measured in the medium of CD1dhighCD5+ Breg cells and CD4+ T cells co-cultured with LPS, PMA and ionomycin. Bar graphs
indicate mean ±SD of 3–5 experiments in which CD1dhighCD5+ Breg cells pooled from 6–10 mice were analyzed. *p<0.05, **p<0.02 (Student’s t-test).
doi:10.1371/journal.pone.0139729.g003
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Conclusions
Our observations uncovered additional characteristics of the defective compartment of regula-
tory B cells that develops in the absence of WASp expression and provides possible insights
into the development of autoimmunity with increasing age in patients affected with WAS.
Supporting Information
S1 Fig. Gating strategy for evaluation of CD1highCD5+ Breg cells.
(PDF)
Fig 4. Activation status of CD1dhighCD5+ Breg cells before/after LPI stimulation. a: Representative flow-cytometry histograms showing the expression
of CD69 on CD1dhighCD5+ Breg cells. Gray curves indicate isotype staining of the CD1dhighCD5+ Breg cells. Thin and thick lines indicate CD69 expression
before and after LPI stimulation, respectively. b: CD69 expression intensity on CD1dhighCD5+ Breg cells before LPI stimulation expressed as geometric
mean. c: Change in intensity of CD69 expression on CD1dhighCD5+ Breg cells after LPI stimulation. Data are expressed as ΔMFI, calculated as in Fig 3b.
Data are mean and SD of samples obtained from 6–10 mice in each assays and repeated 3–5 times. *p<0.001 (Student’s t-test).
doi:10.1371/journal.pone.0139729.g004
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